Alterity Therapeutics (ATHE) Shares Outstanding (2018 - 2025)

Alterity Therapeutics' Shares Outstanding history runs 8 years deep, the most recent figure standing at $5.8 billion for Q2 2025.

• In Q2 2025, Shares Outstanding rose 69.11% year-over-year to $5.8 billion; the TTM figure through Jun 2025 stood at $5.8 billion (up 69.11% YoY), while the FY2025 annual figure was $5.8 billion, up 69.11% from the prior year.
• Shares Outstanding was $5.8 billion for Q2 2025 at Alterity Therapeutics, up from $3.5 billion in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $5.8 billion in Q2 2025 to a low of $1.6 billion in Q2 2021.
• Historically, Shares Outstanding has averaged $2.9 billion across 5 years, with a median of $1.7 billion in 2022.
• The sharpest annual moves came in 2021 and 2023: Shares Outstanding soared 136.03% in 2021, then fell 5.41% in 2023.
• A 5-year view of Shares Outstanding shows it stood at $1.6 billion in 2021, then increased by 7.43% to $1.7 billion in 2022, then declined by 5.41% to $1.6 billion in 2023, then surged by 111.97% to $3.5 billion in 2024, then jumped by 69.11% to $5.8 billion in 2025.
• The last three Shares Outstanding figures came in at $5.8 billion (Q2 2025), $3.5 billion (Q2 2024), and $1.6 billion (Q2 2023), per Business Quant data.